Filing Details

Accession Number:
0001209191-23-002464
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-06 18:32:19
Reporting Period:
2023-01-04
Accepted Time:
2023-01-06 18:32:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1618756 Restaurant Brands International Inc. QSR Retail-Eating Places (5812) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1908102 Duncan Fulton C/O Restaurant Brands International Inc.
5707 Blue Lagoon Drive
Miami FL 33126
Chief Corporate Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2023-01-04 64 $0.00 15,444 No 4 A Direct
Common Shares Disposition 2023-01-04 4,146 $65.04 11,298 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Restricted Share Units Acquisiton 2023-01-04 26 $0.00 26 $0.00
Common Shares Restricted Share Units Acquisiton 2023-01-04 24 $0.00 24 $0.00
Common Shares Performance Share Units Acquisiton 2023-01-04 479 $0.00 479 $0.00
Common Shares Performance Share Units Acquisiton 2023-01-04 232 $0.00 232 $0.00
Common Shares Restricted Share Units Acquisiton 2023-01-04 25 $0.00 25 $0.00
Common Shares Restricted Share Units Acquisiton 2023-01-04 30 $0.00 30 $0.00
Common Shares Performance Share Units Acquisiton 2023-01-04 149 $0.00 149 $0.00
Common Shares Restricted Share Units Acquisiton 2023-01-04 73 $0.00 73 $0.00
Common Shares Performance Share Units Acquisiton 2023-01-04 211 $0.00 211 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,138 No 4 A Direct
2,946 No 4 A Direct
57,666 2024-02-22 2024-02-22 No 4 A Direct
27,994 2025-02-21 2025-02-21 No 4 A Direct
2,953 No 4 A Direct
3,595 No 4 A Direct
17,988 2024-02-19 2024-02-19 No 4 A Direct
8,747 No 4 A Direct
25,388 2025-02-25 2022-02-25 No 4 A Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Shares Option (Right to Buy) $63.64 2023-08-03 2028-08-03 60,000 60,000 Direct
Common Shares Option (Right to Buy) $66.31 2025-02-21 2030-02-21 15,000 15,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2028-08-03 60,000 60,000 Direct
2030-02-21 15,000 15,000 Direct
Footnotes
  1. Represents shares settled from dividend equivalent rights that accrued on a vested restricted share unit award in respect of dividends that were paid after the vesting of the award with a record date prior to the vesting of the award.
  2. Represents shares sold to cover withholding tax obligations on the settlement of the previously reported vesting of the Reporting Person's restricted share units.
  3. The reported shares were sold in Canadian dollars at a price of CAD$87.86 per share. The purchase price was converted into its U.S. dollar equivalent using the Bank of Canada daily exchange rate on the sale date.
  4. Each restricted share unit represents a contingent right to receive one common share.
  5. Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.
  6. These restricted share units vest on December 31, 2023.
  7. These restricted share units vest on December 31, 2024.
  8. The share reported represent an award of performance base restricted share units (the "2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2024, which is the fifth anniversary of the grant date.
  9. Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue whenand as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate.
  10. The share reported represent an award of performance base restricted share units (the "2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date.
  11. These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023.
  12. These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024.
  13. The share reported represent an award of performance base restricted share units (the "2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning on January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.
  14. These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 25, 2025.
  15. The share reported represent an award of performance base restricted share units (the "2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning on January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.